INVASIVE ASPERGILLOSIS
Clinical trials for INVASIVE ASPERGILLOSIS explained in plain language.
Never miss a new study
Get alerted when new INVASIVE ASPERGILLOSIS trials appear
Sign up with your email to follow new studies for INVASIVE ASPERGILLOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cresemba under the microscope: Real-World safety check for fungal infections
Disease control CompletedThis study looked at how safe and effective the drug Cresemba (isavuconazole) is for Korean patients with serious fungal infections like invasive aspergillosis or mucormycosis. Researchers tracked side effects and how well the drug worked in 94 adults. The goal was to confirm the…
Matched conditions: INVASIVE ASPERGILLOSIS
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Hospital study tracks deadly fungus and a possible predictor of patient outcomes
Knowledge-focused CompletedThis observational study at Hospital H+ Querétaro looked at 150 patients with suspected or confirmed invasive aspergillosis, a serious fungal infection. Researchers measured a substance called galactomannan in lung fluid samples to see if higher levels were linked to worse outcom…
Matched conditions: INVASIVE ASPERGILLOSIS
Sponsor: Hospital H+ Queretaro • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to perfect antifungal dosing for sickest ICU patients
Knowledge-focused CompletedThis study looked at 32 adults in the ICU on ECMO life support who had severe influenza or COVID-19 and a serious fungal lung infection called aspergillosis. Researchers measured how the antifungal drug voriconazole behaves in the body to find the best dose for these very ill pat…
Matched conditions: INVASIVE ASPERGILLOSIS
Sponsor: University Hospitals, Leicester • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Real-World study examines Isavuconazole's effectiveness against deadly fungal infections
Knowledge-focused CompletedThis completed study looked at medical records of 307 adults in five European countries who were treated with the antifungal drug isavuconazole for serious fungal infections (invasive aspergillosis or mucormycosis). Researchers tracked how well the drug worked (clinical, radiolog…
Matched conditions: INVASIVE ASPERGILLOSIS
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC